The stock's fall snapped a two-day winning streak.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare ...

Grail (GRAL) stock shot up 33% Thursday, the day after the company announced a partnership with Quest (DGX) to expand ...

Shares of Quest Diagnostics Inc. DGX advanced 1.57% to $165.19 Monday, on what proved to be an all-around favorable trading ...

Quest Diagnostics (NYSE:DGX – Get Free Report) had its target price hoisted by investment analysts at UBS Group from $166.00 ...

Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2024 results topping the market’s revenue ...

Within brain health, the robust demand for AD-detect blood tests for assessing Alzheimer's disease risk drives solid growth ...

State of Alaska Department of Revenue reduced its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 32.6 ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

Grail (GRAL) and Quest Diagnostics (DGX) announced the initial phase of a program to improve provider access to GRAIL’s Galleri multi-cancer ...